BOBBI DURST: Open Payments
NPI 1407405566 · PEWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,697 in 184 payments from 16 companies in 2025. Trend: 2023 $615 · 2024 $2,362 · 2025 $17,697
Honoraria: $13,400Food & beverage: $2,733Travel & lodging: $1,453Education: $111
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 65 | $15,699 |
| Teva Pharmaceuticals USA, Inc. | 13 | $352 |
| Otsuka America Pharmaceutical, Inc. | 15 | $249 |
| ABBVIE INC. | 19 | $214 |
| Corium, LLC | 14 | $194 |
| Lundbeck LLC | 10 | $183 |
| Tris Pharma Inc | 4 | $180 |
| Alkermes, Inc. | 10 | $176 |
| Axsome Therapeutics, Inc. | 17 | $153 |
| Collegium Pharmaceutical, Inc. | 3 | $60 |
Products named: Qelbree, REXULTI, Azstarys, Dyanavel XR, VRAYLAR, Auvelity, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across WI — which companies pay providers there.
